MiR-491-5pはB4GalT5を標的とし,肺酸化ストレスを調節することにより,喘息の炎症と再構成を緩和する
Fan Gao1, He Zhu1, Jiahui Lei1
1Department of Pulmonary and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, People's Republic of China.
Journal of inflammation research
|September 2, 2025
まとめ
マイクロRNA-491-5p (miR-491-5p) は,喘息においてダウンレギュレーションされる. miR-491-5pの回復はB4GalT5を標的とし,呼吸道炎症,再構成,酸化ストレスを軽減します.
科学分野:
- 肺医学
- 分子生物学
- 細胞生物学
背景:
- 喘息の病原化には 呼吸道の再編成と炎症が含まれます
- 喘息におけるマイクロRNA-491-5p (miR-491-5p) の役割は十分に理解されていません.
- この研究は,B4GalT5と酸化ストレスに焦点を当てて,喘息におけるmiR-491-5pのメカニズムを調査しています.
研究 の 目的:
- 喘息の病原性におけるmiR-491-5pの役割を調査する.
- 呼吸道滑らかな筋肉細胞の miR-491-5p の下流標的を特定する.
- miR-491-5pが呼吸道炎症,リモデリング,酸化ストレスに与える影響を調査する.
主な方法:
- ダウンレギュレーションされたmiR- 491-5pが検出されました.
- B4GalT5は,二重ルシフェラーゼアッセイを用いて直接的なmiR-491-5p標的として検証された.
- miR- 491 - 5pの機能を評価するために,卵白素誘発性喘息のマウスモデルとインビトロ細胞培養モデルを使用した.
主要な成果:
- miR- 491 - 5pは,喘息患者の滑らかな筋肉組織でダウン調節された.
- B4GalT5の発現は,呼吸道改造マーカー (Ki-67,WA%) と正に相関していた.
- miR- 491 - 5pの回復は,B4GalT5をターゲットにすることで,体内および体外で呼吸道炎症,再構成,および酸化ストレスを改善しました.
結論:
- miR- 491 - 5pは,喘息の予防に役立っています.
- miR-491-5pによってB4GalT5をターゲットにすると,呼吸道炎症と再形成が軽減されます.
- miR- 491-5pは,喘息の潜在的治療標的である.
関連する概念動画
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:19Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
449
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
449